Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17126415 | 0.96 | HSP90AA1 (0.33) | — | |
| SCHEMBL20102264 | 0.96 | HSP90AA1 (0.33) | — | |
| SCHEMBL17126750 | 0.94 | PLA2G2A (0.34) | PLA2G2APLA2G4AKDM4EALDH1A1MAPT | |
| SCHEMBL9916307 | 0.94 | PLA2G2A (0.34) | PLA2G2APLA2G4AKDM4EALDH1A1MAPT | |
| SCHEMBL10110068 | 0.94 | PLA2G2A (0.34) | PLA2G2APLA2G4AKDM4EALDH1A1MAPT | |
| SCHEMBL9916628 | 0.94 | PLA2G2A (0.34) | PLA2G2APLA2G4AKDM4EALDH1A1MAPT | |
| SCHEMBL14295370 | 0.93 | HSP90AA1 (0.31) | KDM4EALDH1A1MAPTHPGDPGR | |
| SCHEMBL14295378 | 0.93 | HSP90AA1 (0.31) | KDM4EALDH1A1MAPTHPGDPGR | |
| SCHEMBL17126428 | 0.93 | HSP90AA1 (0.33) | PLA2G2APLA2G4AKDM4EALDH1A1MAPT | |
| SCHEMBL9916658 | 0.93 | PLA2G2A (0.34) | PLA2G2APLA2G4AKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180123042-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
| US-20180123042-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180123042-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | OR10J3, BMI1, ETV6 | PLA2G2A 4388/4885PLA2G4A 4595/4885KDM4E 290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.